Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Development plans updated for CPP-109 in drug addiction

Jan. 5, 2007

Outlicensing activities continue for CYT002-NicQb in nicotine addiction

Dec. 27, 2006

FDA approves Cyanokit for cyanide poisoning

Dec. 19, 2006

Novel CRH-R1 antagonist shows potential for the treatment of alcohol abuse

Dec. 19, 2006

Champix launched in U.K.

Dec. 4, 2006

Lundbeck and Biotie sign agreement for nalmefene

Nov. 29, 2006

New series of synthetic CLIP-derived peptides disclosed in recent patent

Nov. 27, 2006

Novel CYP2A inhibitors for smoking cessation patented by InflaZyme

Nov. 2, 2006

Probuphine begins phase III trial for treatment of opioid dependence

Oct. 30, 2006

Sazetidine-A: a new desensitizing nicotinic ligand

Oct. 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...